- Cohen SJ, Alpaugh RK, Gross S, O’Hara SM,
Smirnov DA, Terstappen LW, Allard WJ,
Bilbee M, Cheng JD, Hoffman JP, Lewis NL,
Pellegrino A, Rogatko A, Sigurdson E,
Wang H, Watson JC, Weiner LM, Meropol
NJ (2006) Isolation and characterization of
circulating tumour cells in patients with meta-
static colorectal cancer. Clin Colorectal Cancer
6(2):125–132. https://doi.org/10.3816/
CCC.2006.n.029
- Cristofanilli M, Budd GT, Ellis MJ, Stopeck A,
Matera J, Miller MC, Reuben JM, Doyle GV,
Allard WJ, Terstappen LW, Hayes DF (2004)
Circulating tumour cells, disease progression,
and survival in metastatic breast cancer. N Engl
J Med 351(8):781–791.https://doi.org/10.
1056/NEJMoa040766
- Moreno JG, O’Hara SM, Gross S, Doyle G,
Fritsche H, Gomella LG, Terstappen LW
(2001) Changes in circulating carcinoma cells
in patients with metastatic prostate cancer cor-
relate with disease status. Urology 58
(3):386–392. https://doi.org/10.1016/
S0090-4295(01)01191-8
- Diehl F, Schmidt K, Choti MA, Romans K,
Goodman S, Li M, Thornton K, Agrawal N,
Sokoll L, Szabo SA, Kinzler KW, Vogelstein B,
Diaz LA Jr (2008) Circulating mutant DNA to
assess tumour dynamics. Nat Med 14
(9):985–990. https://doi.org/10.1038/nm.
1789
- Diehl F, Li M, Dressman D, He Y, Shen D,
Szabo S, Diaz LA Jr, Goodman SN, David KA,
Juhl H, Kinzler KW, Vogelstein B (2005)
Detection and quantification of mutations in
the plasma of patients with colorectal tumours.
Proc Natl Acad Sci U S A 102
(45):16368–16373. https://doi.org/10.
1073/pnas.0507904102.
- Bettegowda C, Sausen M, Leary RJ, Kinde I,
Wang Y, Agrawal N, Bartlett BR, Wang H,
Luber B, Alani RM, Antonarakis ES, Azad
NS, Bardelli A, Brem H, Cameron JL, Lee
CC, Fecher LA, Gallia GL, Gibbs P, Le D,
Giuntoli RL, Goggins M, Hogarty MD,
Holdhoff M, Hong SM, Jiao Y, Juhl HH,
Kim JJ, Siravegna G, Laheru DA,
Lauricella C, Lim M, Lipson EJ, Marie SK,
Netto GJ, Oliner KS, Olivi A, Olsson L, Rig-
gins GJ, Sartore-Bianchi A, Schmidt K, Shih
lM, Oba-Shinjo SM, Siena S, Theodorescu D,
Tie J, Harkins TT, Veronese S, Wang TL,
Weingart JD, Wolfgang CL, Wood LD,
Xing D, Hruban RH, Wu J, Allen PJ, Schmidt
CM, Choti MA, Velculescu VE, Kinzler KW,
Vogelstein B, Papadopoulos N, Diaz LA Jr
(2014) Detection of circulating tumour DNA
in early-and late-stage human malignancies. Sci
Transl Med 6(224):224ra224-224ra224.
https://doi.org/10.1126/scitranslmed.
3007094
- Bidard FC, Madic J, Mariani P, Piperno-
Neumann S, Rampanou A, Servois V,
Cassoux N, Desjardins L, Milder M,
Vaucher I, Pierga JY, Lebofsky R, Stern MH,
Lantz O (2014) Detection rate and prognostic
value of circulating tumour cells and circulating
tumour DNA in metastatic uveal melanoma.
Int J Cancer 134(5):1207–1213.https://doi.
org/10.1002/ijc.28436
- Freidin MB, Freydina DV, Leung M, Fernan-
dez AM, Nicholson AG, Lim E (2015) Circu-
lating tumour DNA outperforms circulating
tumour cells for KRAS mutation detection in
thoracic malignancies. Clin Chem 61
(10):1299–1304. https://doi.org/10.1373/
clinchem.2015.242453
- Matsuda K, Maruyama H, Guo F, Kleeff J,
Itakura J, Matsumoto Y, Lander AD, Korc M
(2001) Glypican-1 is overexpressed in human
breast cancer and modulates the mitogenic
effects of multiple heparin-binding growth fac-
tors in breast cancer cells. Cancer Res 61
(14):5562–5569
- Kleeff J, Ishiwata T, Kumbasar A, Friess H,
Bu ̈chler MW, Lander AD, Korc M (1998)
The cell-surface heparan sulfate proteoglycan
glypican-1 regulates growth factor action in
pancreatic carcinoma cells and is overexpressed
in human pancreatic cancer. J Clin Investig 102
(9):1662.https://doi.org/10.1172/JCI4105
- Melo SA, Luecke LB, Kahlert C, Fernandez
AF, Gammon ST, Kaye J, LeBleu VS, Mitten-
dorf EA, Weitz J, Rahbari N, Reissfelder C,
Pilarsky C, Fraga MF, Piwnica-Worms D, Kal-
luri R (2015) Glypican-1 identifies cancer exo-
somes and detects early pancreatic cancer.
Nature 523(7559):177–182. https://doi.
org/10.1038/nature14581
- Bujanda L, Sarasqueta C, Cosme A, Hijona E,
Enrı ́quez-Navascue ́s JM, Placer C, Villarreal E,
Herreros-Villanueva M, Giraldez MD,
Gironella M, Balaguer F, Castells A (2013)
Evaluation of alpha 1-antitrypsin and the levels
of mRNA expression of matrix metalloprotei-
nase 7, urokinase type plasminogen activator
receptor and COX-2 for the diagnosis of colo-
rectal cancer. PLoS One 8(1):e51810.https://
doi.org/10.1371/journal.pone.0051810
- Lim SH, Spring KJ, de Souza P, MacKenzie S,
Bokey L (2015) Circulating tumour cells and
circulating nucleic acids as a measure of tumour
dissemination in non-metastatic colorectal can-
cer surgery. Eur J Surg Oncol 41(3):309–314.
https://doi.org/10.1016/j.ejso.2014.12.005
- Rodia MT, Ugolini G, Mattei G, Montroni I,
Zattoni D, Ghignone F, Veronese G, Marisi G,
Lauriola M, Strippoli P, Solmi R (2016)
The Introduction and Clinical Application of Cell-Free Tumor DNA 61
